Stocks Taking Flight: Tech, Biotech & Auto Picks Heating Up

July 24, 2025

DENVER, Colo., Jul 24, 2025 (247marketnews.com)- A diverse mix of stocks is showing momentum in the past 24 hours, from EV and spatial computing to aerospace and fintech. Here’s a breakdown of today’s breakout movers:

AEye (NASDAQ:LIDR) announced the full integration of its Apollo lidar sensor into NVIDIA’s DRIVE AGX platform. Becoming a certified supplier to NVIDIA’s global automaker network puts AEye in the driver’s seat and paves the way for millions of vehicles to include AEye’s lidar.

CEO Matt Fisch stated, “Apollo’s industry‑leading 1‑kilometer range and compact form factor make it a standout solution … we have a powerful channel to scale commercially across the automotive industry.”

Venu’s (NYSE:VENU) trading interest is spiking as the Regulation A Preferred Offering winds down today, with $14 being a key resistance with upside to $22.30, per Cenorium AG.
Highlights:

  • Only 4.04M float, 37.52M shares outstanding, and significant short interest
  • CEO J.W. Roth has invested $5M personally, with plans to escalate to $20M
  • Luxe FireSuite revenue grew 250% YoY, targeting $300M in 2025
  • Structuring $200M in non-dilutive debt via Texas Capital Securities

Incannex Healthcare’s (NASDAQ:IXHL) ongoing warrant reductions clean up future dilution and anticipates Phase 3 readiness for its insomnia therapy IHL‑42X.

AgEagle Aerial Systems (NYSE:UAVS) delivered its 100th eBee drone to South Korea, and is launching AI-teamed drone systems through a new partnership with an Israeli firm. Growth signals coming from increased defense and environmental applications.

Liminatus Pharma (NASDAQ:LMNL) is a micro-cap biotech early in development; keep an eye for trial or data updates.

Bloom Energy (NYSE:BE) is a solid fuel cell energy tech player.

Faraday Future Intelligent Electric (NASDAQ:FFIE) officially unveiled its FX Super One luxury electric MPV with an AI‑LED “F.A.C.E.” grille, priced around $70K, production starting 2025, sales 2026.

Cyclacel Pharmaceuticals (NASDAQ:CYCC) investor focus remains on its recent stock split and potential impact of its convertible preferred offering.

MaxLinear’s (NASDAQ:MXL) IBD RS rating climbs from 64 to 71, signaling improved performance and MaxLinear G.hn transceivers power new 5G repeaters from Morelink, ultra-low power 5G coverage that meets network demand.

Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.

Please go to https://247marketnews.com/venu-disclosure/ for additional VENU disclosure.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (VENU, LIDR, IXHL, LMNL, BE, FFIE)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.